ArticleMolecular diversity2026

In silico discovery of natural and synthetic inhibitors targeting AKT1 in prostate cancer.

Hemantha Mani Kumar Chakravarthi Chanda et al.PubMed ↗Publisher ↗

No numbers read from the abstract.